Intercomparison of 131I and 99mTc activity measurements in Brazilian nuclear medicine services.
This work outlines the quality assurance program for the activity measurements of the most used radionuclides at Brazilian Nuclear Medicine Services (NMS). The program aims to guarantee that the patient is given the correct prescribed amount of activity in diagnostic or therapeutic applications. This accurate administration depends upon proper use and calibration of the activity meters by the NMS. Underestimation of administered activity in diagnostic practices could delay correct diagnosis disturbing the value of the investigation. On the other hand, the overestimation would be worse, mainly in therapeutic applications, because an unnecessarily high absorbed dose would be delivered to the patient. The preliminary results of intercomparison for 131I and 99mTc showed that many activity meters used at NMS's present problems giving results up to 41% greater than the reference values determined at the National Metrology Laboratory for Ionizing Radiation (LNMRI) which is recognized as the Brazilian authorized metrology laboratory for ionizing radiation. These results have demonstrated that the NMS should improve the accuracy of the activity measurements of the radionuclides administered to the patients and establish the traceability to the national standards of measurements. These standards are based on a pressurized well-type ionization chamber installed at LNMRI and calibrated with reference sources standardized by absolute methods. The protocol of the intercomparison and recommendations made in order to minimize errors in measuring procedures are described and results are discussed.
Iwahara
A
A
Laboratório Nacional de Metrologia das Radiações Ionizantes-Instituto de Radioproteção e Dosimetria, Comissão Nacional de Energia Nuclear, Rio de Janeiro, Brazil. iwahara@ird.gov.br
De Oliveira
A E
AE
Tauhata
L
L
da Silva
C J
CJ
Lopes
R T
RT
D001938:Brazil; D006801:Humans; D009683:Nuclear Medicine / Q000592:standards*; D011786:Quality Control; D019275:Radiopharmaceuticals / Q000032:analysis* / Q000592:standards*; D013667:Technetium / Q000032:analysis* / Q000592:standards*
D019275:Radiopharmaceuticals; D013667:Technetium